Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes

D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.

Guardado en:
Detalles Bibliográficos
Autores principales: Dimitrios Evangelopoulos, Gareth A. Prosser, Angela Rodgers, Belinda M. Dagg, Bhagwati Khatri, Mei Mei Ho, Maximiliano G. Gutierrez, Teresa Cortes, Luiz Pedro S. de Carvalho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd1574c81b52465e9b1150a6fda379b5
record_format dspace
spelling oai:doaj.org-article:cd1574c81b52465e9b1150a6fda379b52021-12-02T16:58:02ZComparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes10.1038/s41467-019-12074-z2041-1723https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b52019-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12074-zhttps://doaj.org/toc/2041-1723D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.Dimitrios EvangelopoulosGareth A. ProsserAngela RodgersBelinda M. DaggBhagwati KhatriMei Mei HoMaximiliano G. GutierrezTeresa CortesLuiz Pedro S. de CarvalhoNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Dimitrios Evangelopoulos
Gareth A. Prosser
Angela Rodgers
Belinda M. Dagg
Bhagwati Khatri
Mei Mei Ho
Maximiliano G. Gutierrez
Teresa Cortes
Luiz Pedro S. de Carvalho
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
description D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.
format article
author Dimitrios Evangelopoulos
Gareth A. Prosser
Angela Rodgers
Belinda M. Dagg
Bhagwati Khatri
Mei Mei Ho
Maximiliano G. Gutierrez
Teresa Cortes
Luiz Pedro S. de Carvalho
author_facet Dimitrios Evangelopoulos
Gareth A. Prosser
Angela Rodgers
Belinda M. Dagg
Bhagwati Khatri
Mei Mei Ho
Maximiliano G. Gutierrez
Teresa Cortes
Luiz Pedro S. de Carvalho
author_sort Dimitrios Evangelopoulos
title Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
title_short Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
title_full Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
title_fullStr Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
title_full_unstemmed Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
title_sort comparative fitness analysis of d-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b5
work_keys_str_mv AT dimitriosevangelopoulos comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT garethaprosser comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT angelarodgers comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT belindamdagg comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT bhagwatikhatri comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT meimeiho comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT maximilianoggutierrez comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT teresacortes comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
AT luizpedrosdecarvalho comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes
_version_ 1718382415842377728